Genfit (Genfit) EV-to-Revenue : 11.72 (As of May. 24, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Genfit EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Genfit's enterprise value is $217.65 Mil. Genfit's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $18.56 Mil. Therefore, Genfit's EV-to-Revenue for today is 11.72.

The historical rank and industry rank for Genfit's EV-to-Revenue or its related term are showing as below:

GNFT' s EV-to-Revenue Range Over the Past 10 Years
Min: 6.41 Med: 11 Max: 38.31
Current: 11.29

During the past 13 years, the highest EV-to-Revenue of Genfit was 38.31. The lowest was 6.41. And the median was 11.00.

GNFT's EV-to-Revenue is ranked worse than
57.9% of 1038 companies
in the Biotechnology industry
Industry Median: 8.22 vs GNFT: 11.29

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-24), Genfit's stock price is $4.53. Genfit's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.37. Therefore, Genfit's PS Ratio for today is 12.18.

Genfit EV-to-Revenue Historical Data

The historical data trend for Genfit's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genfit EV-to-Revenue Chart

Genfit Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

19.22

221.63

0.38

6.56

5.91

Genfit Quarterly Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															35.66	6.56	12.10	17.56	5.91

Competitive Comparison of Genfit's EV-to-Revenue

For the Biotechnology subindustry, Genfit's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genfit's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genfit's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Genfit's EV-to-Revenue falls into.

Genfit EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Genfit's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	217.646	/	18.563
	=	11.72

Genfit's current Enterprise Value is $217.65 Mil.
Genfit's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $18.56 Mil.

Genfit (NAS:GNFT) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Genfit's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	4.53	/	0.372
	=	12.18

Genfit's share price for today is $4.53.
Genfit's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.37.

Genfit EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Genfit's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Genfit (Genfit) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genfit SA (NAS:GNFT) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

GNFTF:USA 0QT6:UK GNFT:France XUPB:Germany

Address

Parc Eurasante, 885, Avenue Eugene Avinee, Loos, FRA, 59120

Website

https://www.genfit.com

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. The company conducts clinical trials in a variety of European and North American countries when advancing through stages of development. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.